In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Kucera, Otto ^a   Mezera, Vojtech ^a   Moravcova, Alena ^a   Endlicher, Rene ^a   Lotkova, Halka ^a   Drahota, Zdenek ^a   Cervinkova, Zuzana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; MOBILE SECURITY; RATS;

EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN-3-GALLATE; HEPATOCYTE FUNCTIONS; MITOCHONDRIAL MEMBRANE POTENTIAL; OUTER MITOCHONDRIAL MEMBRANES; OXIDATIVE PHOSPHORYLATION; RAT LIVER MITOCHONDRIA; REACTIVE OXYGEN SPECIES;

MITOCHONDRIA;

ALBUMIN; CASPASE 3; CASPASE 8; CASPASE 9; EPIGALLOCATECHIN GALLATE; LACTATE DEHYDROGENASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; CATECHIN; TEA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; DOSE RESPONSE; DRUG CYTOTOXICITY; ENZYME ACTIVITY; IN VITRO STUDY; INCUBATION TIME; LIPID PEROXIDATION; LIVER CELL; LIVER CELL CULTURE; LIVER CELL DAMAGE; LIVER MITOCHONDRION; LIVER TOXICITY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIMARY CULTURE; RAT; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; METABOLISM; TEA; WISTAR RAT;

RATTUS;

ANIMALS; CASPASE 3; CATECHIN; CELL SURVIVAL; CELLS, CULTURED; HEPATOCYTES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA, LIVER; OXIDATIVE PHOSPHORYLATION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928485185     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/476180     Document Type: Article

References (71)

1. H.-S. Kim, M. J. Quon, and J.-A. Kim, "New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate," Redox Biology, vol. 2, no. 1, pp. 187-195, 2014.
2. A. Moravcova, Z. Cervinkova, O. Kucera, V. Mezera, and H. Lotkova, "Antioxidative effect of epigallocatechin gallate against D-galactosamine-induced injury in primary culture of rat hepatocytes," Acta Medica, vol. 57, no. 1, pp. 3-8, 2014.
3. S. Thangapandiyan and S. Miltonprabu, "Epigallocatechin gallate effectively ameliorates fluoride-induced oxidative stress and DNAdamage in the liver of rats,"Canadian Journal of Physiology and Pharmacology, vol. 91, no. 7, pp. 528-537, 2013.
4. N. Kuzu, I. H. Bahcecioglu, A. F. Dagli, I. H. Ozercan, B. Ustundag, and K. Sahin, "Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet," Journal of Gastroenterology and Hepatology, vol. 23, no. 8, part 2, pp. e465-e470, 2008.
5. K. Sahin, M. Tuzcu, H. Gencoglu et al. , "Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatininduced nephrotoxicity in rats," Life Sciences, vol. 87, no. 7-8, pp. 240-245, 2010.
6. S. Thangapandiyan and S. Miltonprabu, "Epigallocatechin gallate supplementation protects against renal injury induced by fluoride intoxication in rats: role of Nrf2/HO-1 signaling," Toxicology Reports, vol. 1, pp. 12-30, 2014.
7. M. Akhlaghi and B. Bandy, "Preconditioning and acute effects of flavonoids in protecting cardiomyocytes from oxidative cell death," Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 782321, 9 pages, 2012.
8. P. T. Devika and P. Stanely Mainzen Prince, "(-)Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic and in vitro study," Pharmacological Research, vol. 57, no. 5, pp. 351-357, 2008.
9. N. Sriram, S. Kalayarasan, and G. Sudhandiran, "Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling," Pulmonary Pharmacology andTherapeutics, vol. 22,no. 3, pp. 221-236, 2009.
10. Y.-J. Surh, J. K. Kundu, and H.-K. Na, "Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals," Planta Medica, vol. 74, no. 13, pp. 1526-1539, 2008.
11. J. D. Lambert and R. J. Elias, "The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention," Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 65-72, 2010.
12. H. Raza and A. John, "In vitro protection of reactive oxygen species-induced degradation of lipids, proteins and 2-deoxyribose by tea catechins," Food and Chemical Toxicology, vol. 45, no. 10, pp. 1814-1820, 2007.
13. S. G. Han, S.-S. Han, M. Toborek, and B. Hennig, "EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes," Toxicology and Applied Pharmacology, vol. 261, no. 2, pp. 181-188, 2012.
14. Y.-L. Lin, C.-Y. Cheng, Y.-P. Lin, Y.-W. Lau, I.-M. Juan, and J.-K. Lin, "effect of green tea leaves through induction of antioxidant and phase II enzymes including superoxide dismutase, catalase, and glutathione S-transferase in rats," Journal of Agricultural and Food Chemistry, vol. 46, no. 5, pp. 1893-1899, 1998.
15. S. G. Khan, S. K. Katiyar, R. Agarwal, and H. Mukhtar, "Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention," Cancer Research, vol. 52, no. 14, pp. 4050-4052, 1992.
16. G. L. Tipoe, T. M. Leung, E. C. Liong, T. Y. H. Lau, M. L. Fung, and A. A. Nanji, "Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice," Toxicology, vol. 273, no. 1-3, pp. 45-52, 2010.
17. F. Yang, H. S. Oz, S. Barve,W. J. S. deVilliers, C. J. McClain, and G. W. Varilek, "The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-κB activation by inhibiting IκB kinase activity in the intestinal epithelial cell line IEC-6," Molecular Pharmacology, vol. 60, no. 3, pp. 528-533, 2001.
18. D. E. Giakoustidis, A. E. Giakoustidis, S. Iliadis et al. , "Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-κB and c-Jun expression," Journal of Surgical Research, vol. 159, no. 2, pp. 720-728, 2010.
19. E. H. Byun, Y. Fujimura, K. Yamada, and H. Tachibana, "TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor," The Journal of Immunology, vol. 185, no. 1, pp. 33-45, 2010.
20. Y. Yasuda,M. Shimizu, H. Sakai et al. , "(-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R," Chemico-Biological Interactions, vol. 182, no. 2-3, pp. 159-164, 2009.
21. M.-C. Zhen, Q. Wang, X.-H. Huang et al. , "Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis," Journal of Nutritional Biochemistry, vol. 18, no. 12, pp. 795-805, 2007.
22. J.-H. Chen, G. L. Tipoe, E. C. Liong et al. , "Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants," The American Journal of Clinical Nutrition, vol. 80, no. 3, pp. 742-751, 2004.
23. F. Yumei, Y. Zhou, S. Zheng, and A. Chen, "The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells," Laboratory Investigation, vol. 86, no. 7, pp. 697-709, 2006.
24. H. S. Oz and T. S. Chen, "Green-tea polyphenols downregulate cyclooxygenase and Bcl-2 activity in acetaminophen-induced hepatotoxicity," Digestive Diseases and Sciences, vol. 53, no. 11, pp. 2980-2988, 2008.
25. K. Abe, M. Ijiri, T. Suzuki, K. Taguchi, Y. Koyama, and M. Isemura, "Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver," Biomedical Research, vol. 26, no. 5, pp. 187-192, 2005.
26. J. Zhou, B. L. Farah, R. A. Sinha et al. , "Epigallocatechin-3-Gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance," PLoS ONE, vol. 9, no. 1, Article ID e87161, 2014.
27. M.-Y. Chung, H. J. Park, J. E. Manautou, S. I. Koo, and R. S. Bruno, "Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes," The Journal of Nutritional Biochemistry, vol. 23, no. 4, pp. 361-367, 2012.
28. R. N. Fiorini, J. L. Donovan, D. Rodwell et al. , "Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice," Liver Transplantation, vol. 11, no. 3, pp. 298-308, 2005.
29. E. Skrzydlewska, J. Ostrowska, R. Farbiszewski, and K. Michalak, "Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain," Phytomedicine, vol. 9, no. 3, pp. 232-238, 2002.
30. E. Skrzydlewska, J. Ostrowska, A. Stankiewicz, and R. Farbiszewski, "Green tea as a potent antioxidant in alcohol intoxication," Addiction Biology, vol. 7, no. 3, pp. 307-314, 2002.
31. G. E. Arteel, T. Uesugi, L. N. Bevan et al. , "Green tea extract protects against early alcohol-induced liver injury in rats," Biological Chemistry, vol. 383, no. 3-4, pp. 663-670, 2002.
32. S. Kaviarasan, R. Sundarapandiyan, and C. V. Anuradha, "Epigallocatechin gallate, a green tea phytochemical, attenuates alcohol-induced hepatic protein and lipid damage," Toxicology Mechanisms and Methods, vol. 18, no. 8, pp. 645-652, 2008.
33. Y. Saito, H. Mori, C. Takasu et al. , "Beneficial effects of green tea catechin on massive hepatectomy model in rats," Journal of Gastroenterology, vol. 49, no. 4, pp. 692-701, 2014.
34. V. Mezera, O. Kucera, A. Moravcova, E. Peterova, and Z. Cervinkova, "Epigallocatechin gallate does not accelerate the early phase of liver regeneration after partial hepatectomy in rats," Digestive Diseases and Sciences, vol. 59, no. 5, pp. 976-985, 2014.
35. S. K. Katiyar, F. Afaq, A. Perez, and H. Mukhtar, "Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress," Carcinogenesis, vol. 22, no. 2, pp. 287-294, 2001.
36. M. H. Lee, B.-J. Kwon, M.-A. Koo, K. E. You, and J.-C. Park, "Mitogenesis of vascular smooth muscle cell stimulated by platelet-derived growth factor-bb is inhibited by blocking of intracellular Signaling by epigallocatechin-3-O-gallate," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 827905, 10 pages, 2013.
37. M. A. Potenza, F. L. Marasciulo, M. Tarquinio et al. , "EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR," American Journal of Physiology-Endocrinology and Metabolism, vol. 292, no. 5, pp. E1378-E1387, 2007.
38. M. Lorenz, S. Wessler, E. Follmann et al. , "A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation,"TheJournal of Biological Chemistry, vol. 279, no. 7, pp. 6190-6195, 2004.
39. P. Hirsova, G. Kolouchova, E. Dolezelova et al. , "Epigallocatechin gallate enhances biliary cholesterol secretion in healthy rats and lowers plasma and liver cholesterol in ethinylestradioltreated rats," European Journal of Pharmacology, vol. 691, no. 1-3, pp. 38-45, 2012.
40. M. Jimenez-Saenz and M. d. C. Martinez-Sanchez, "Acute hepatitis associated with the use of green tea infusions," Journal of Hepatology, vol. 44, no. 3, pp. 616-617, 2006.
41. J. D. Lambert, M. J. Kennett, S. Sang, K. R. Reuhl, J. Ju, and C. S. Yang, "Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice," Food and Chemical Toxicology, vol. 48, no. 1, pp. 409-416, 2010.
42. M. Schmidt, H.-J. Schmitz,A. Baumgart et al. , "Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture," Food and Chemical Toxicology, vol. 43, no. 2, pp. 307-314, 2005.
43. G. Galati, A. Lin, A. M. Sultan, and P. J. OBrien, "Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins," Free Radical Biology andMedicine, vol. 40, no. 4, pp. 570-580, 2006.
44. H. Nakagawa, K. Hasumi, J.-T. Woo, K. Nagai, and M. Wachi, "Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate," Carcinogenesis, vol. 25, no. 9, pp. 1567-1574, 2004.
45. M. Pohanka, J. Sobotka, and R. Stetina, "Sulfurmustard induced oxidative stress and its alteration by epigallocatechin gallate," Toxicology Letters, vol. 201, no. 2, pp. 105-109, 2011.
46. M. G. Goodin, B. J. Bray, and R. J. Rosengren, "Sex-and strain-dependent effects of epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) in themouse," Food andChemical Toxicology, vol. 44, no. 9, pp. 1496-1504, 2006.
47. D. Valenti, D. de Rasmo, A. Signorile et al. , "Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Downs syndrome," Biochimica et Biophysica Acta, vol. 1832, no. 4, pp. 542-552, 2013.
48. Q. Meng, C. N. Velalar, and R. Ruan, "Regulating the age-related oxidative damage, mitochondrial integrity, and antioxidative enzyme activity in Fischer 344 rats by supplementation of the antioxidant epigallocatechin-3-gallate," Rejuvenation Research, vol. 11, no. 3, pp. 649-660, 2008.
49. S. Kaviarasan, N. Ramamurthy, P. Gunasekaran, E. Varalakshmi, and C. V. Anuradha, "Epigallocatechin-3-gallate(-)protects Chang liver cells against ethanol-induced cytotoxicity and apoptosis," Basic and Clinical Pharmacology and Toxicology, vol. 100, no. 3, pp. 151-156, 2007.
50. J. M. Jimenez-Lopez and A. I. Cederbaum, "Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity," Free Radical Biology andMedicine, vol. 36, no. 3, pp. 359-370, 2004.
51. J. Zheng and V. D. Ramirez, "Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals," British Journal of Pharmacology, vol. 130, no. 5, pp. 1115-1123, 2000.
52. D. Valenti, L. de Bari, G. A. Manente et al. , "Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1832, no. 12, pp. 2085-2096, 2013.
53. Z. Weng, P. Zhou, W. F. Salminen et al. , "Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria," Biochemical and Biophysical Research Communications, vol. 443, no. 3, pp. 1097-1104, 2014.
54. M. N. Berry, A. M. Edwards, and G. J. Barritt, "High-yield preparation of isolated hepatocytes from rat liver," in Isolated Hepatocytes Preparation, Properties and Application, R. H. Burdon and P. H. van Knippenberg, Eds. , pp. 15-58, Elsevier, New York, NY, USA, 1991.
55. O. Kucera, R. Endlicher, T. Rousar et al. , "Theeffect of tert-butyl hydroperoxide-induced oxidative stress on lean and steatotic rat hepatocytes in vitro," OxidativeMedicine and Cellular Longevity, vol. 2014, Article ID752506, 12 pages, 2014.
56. O. Kucera, S. Al-Dury, H. Lotkova, T. Rouar,D. Rychtrmoc, and Z. Cervinkova, "Steatotic rat hepatocytes in primary culture are more susceptible to the acute toxic effect of acetaminophen," Physiological Research, vol. 61, no. 2, pp. S93-S101, 2012.
57. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction," Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
58. Z. Cervinkova, P. Krivakova, A. Labajova et al. , "Mechanisms participating in oxidative damage of isolated rat hepatocytes," Archives of Toxicology, vol. 83, no. 4, pp. 363-372, 2009.
59. V. Mezera, O. Kucera, A. Moravcova, E. Peterova, and Z. Cervinkova, "The effect of epigallocatechin gallate on hepatocytes isolated from normal and partially hepatectomized rats," Canadian Journal of Physiology and Pharmacology, vol. 92, no. 6, pp. 512-517, 2014.
60. L. Chen, M.-J. Lee, H. Li, and C. S. Yang, "Absorption, distribution, and elimination of tea polyphenols in rats," Drug Metabolism and Disposition, vol. 25, no. 9, pp. 1045-1050, 1997.
61. K. Nakagawa and T. Miyazawa, "Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat," Journal of Nutritional Science and Vitaminology, vol. 43, no. 6, pp. 679-684, 1997.
62. R. A. Isbrucker, J. A. Edwards, E. Wolz, A. Davidovich, and J. Bausch, "Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies," Food and Chemical Toxicology, vol. 44, no. 5, pp. 636-650, 2006.
63. K. Nakagawa, S. Okuda, and T. Miyazawa, "Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma," Bioscience, Biotechnology and Biochemistry, vol. 61, no. 12, pp. 1981-1985, 1997.
64. U. Ullmann, J. Haller, J. P. Decourt et al. , "A single ascending dose study of epigallocatechin gallate in healthy volunteers," Journal of International Medical Research, vol. 31, no. 2, pp. 88-101, 2003.
65. F. Bosetti, A. Baracca, G. Lenaz, and G. Solaini, "Increased state 4mitochondrial respiration and swelling in early post-ischemic reperfusion of rat heart,"The FEBS Letters, vol. 563, no. 1-3, pp. 161-164, 2004.
66. R. Lagoa, I. Graziani, C. Lopez-Sanchez, V. Garcia-Martinez, and C. Gutierrez-Merino, "Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria," Biochimica et Biophysica Acta, vol. 1807, no. 12, pp. 1562-1572, 2011.
67. R. N. A. El Naga, S. S. Azab, E. El-Demerdash, S. Shaarawy, M. El-Merzabani, and E.-S. M. Ammar, "Sensitization of TRAILinduced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals," Life Sciences, vol. 92, no. 10, pp. 555-561, 2013.
68. G. J. Gores, B. Herman, and J. J. Lemasters, "Plasma membrane bleb formation and rupture: a common feature of hepatocellular injury," Hepatology, vol. 11, no. 4, pp. 690-698, 1990.
69. G. C. Brown and V. Borutaite, "Regulation of apoptosis by the redox state of cytochrome c," Biochimica et Biophysica Acta, vol. 1777, no. 7-8, pp. 877-881, 2008.
70. D. Vergote, C. Cren-Olive, V. Chopin et al. , "(-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts," Breast Cancer Research and Treatment, vol. 76, no. 3, pp. 195-201, 2002.
71. F. Yang, W. J. S. de Villiers, C. J. McClain, and G. W. Varilek, "Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model," Journal of Nutrition, vol. 128, no. 12, pp. 2334-2340, 1998.